Aethlon Medical Secures FDA Clearance For Amendment In Initial-Stage COVID-19 Study
The U.S. Food and Drug Administration (FDA) has approved an amendment to the protocol of the ongoing clinical trial investigating Aethlon Medical’s (NASDAQ: AEMD) lead therapy Aethlon Hemopurifier for patients with severe COVID-19.
President Biden Says ‘I support the Second Amendment’ But ‘guns are the number one killer of children in the United States’
https://twitter.com/W7VOA/status/1546518384875126789
Johnny Depp Takes Dig At Amber Heard In New Songs: Here Are The Pointed Lyrics
A new music album from Jeff Beck and Johnny Depp features cover songs and some original works. While not naming her directly, Depp appears to take a shot at ex-wife Amber Heard in several songs.
MediWound Posts Early Data From Non-Melanoma Skin Cancer Trial
MediWound Ltd (NASDAQ:MDWD) announced initial data from eleven patients in its ongoing open-label Phase 1/2 study of MW005 for low-risk Basal…
Why Volcon Shares Are Soaring Today
Volcon Inc (NASDAQ:VLCN) has received thousands of non-binding pre-production orders, which, if finalized, would result in more than $70 million worth…
Perrigo Seeks FDA Approval For the First OTC Contraceptive Pill
Perrigo Company plc's (NYSE: PRGO) HRA Pharma has
ViaCyte Acquisition Can Accelerate Vertex’s Ongoing Type 1 Diabetes Programs
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has agreed to acquire ViaCyte, a privately held biotechnology, for $320 million in cash. ViaCyte is focused…